Rapidly Emerging Antiviral Drug Development Initiative
The Rapidly Emerging Antiviral Drug Development Initiative (READDI) is an American non-profit organization based in Chapel Hill, North Carolina. It is a project of the Eshelman Institute for Innovation at the University of North Carolina at Chapel Hill.1)
Organization
Partners
READDI receives funding from the National Institute of Allergy and Infectious Diseases (NIAID), North Carolina General Assembly, North Carolina Policy Collaboratory, and RTI International.2)
Collaborators include the Drugs for Neglected Diseases Initiative (DNDi), SAS and the Structural Genomics Consortium (SGC).
External links
1)
Home. READDI. Retrieved April 9, 2023, from https://web.archive.org/web/20230409071029/https://www.readdi.org/
2)
Partners. READDI. Retrieved February 27, 2023, from http://archive.today/2023.02.27-135816/https://www.readdi.org/partners.html